|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
ELV033121273 |
003 |
DE-627 |
005 |
20230623224649.0 |
007 |
cr uuu---uuuuu |
008 |
180603s2013 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/S0378-3782(13)70083-5
|2 doi
|
028 |
5 |
2 |
|a GBVA2013012000013.pica
|
035 |
|
|
|a (DE-627)ELV033121273
|
035 |
|
|
|a (ELSEVIER)S0378-3782(13)70083-5
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
082 |
0 |
|
|a 610
|
082 |
0 |
4 |
|a 610
|q DE-600
|
082 |
0 |
4 |
|a 618.3/005
|q OCLC
|
082 |
0 |
4 |
|a 610
|q VZ
|
082 |
0 |
4 |
|a 610
|q VZ
|
084 |
|
|
|a 44.45
|2 bkl
|
100 |
1 |
|
|a Indrio, Flavia
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Microbiota in healthy term infant
|
264 |
|
1 |
|c 2013
|
300 |
|
|
|a 3
|
336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
520 |
|
|
|a Development of intestinal microbiota after birth is related to health throughout life. A healthy and balanced gut microbiota profile in infancy is shaped and modulated by different factors as mode of delivery and feeding type. An aberrant compositional development of gut microbiota in early life can be linked to the risk of intestinal or extraintestinal immune-mediated disease later in life.
|
650 |
|
7 |
|a Term newborn
|2 Elsevier
|
650 |
|
7 |
|a Intestinal microbiota
|2 Elsevier
|
650 |
|
7 |
|a Intestinal function
|2 Elsevier
|
650 |
|
7 |
|a Brain developmen
|2 Elsevier
|
700 |
1 |
|
|a Di Mauro, Antonio
|4 oth
|
700 |
1 |
|
|a Riezzo, Giuseppe
|4 oth
|
700 |
1 |
|
|a Di Mauro, Federica
|4 oth
|
700 |
1 |
|
|a Francavilla, Ruggiero
|4 oth
|
773 |
0 |
8 |
|i Enthalten in
|n Elsevier Science
|a Abdel-Aziz, Tarek Ezzat ELSEVIER
|t Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics
|d 2014
|g Amsterdam [u.a.]
|w (DE-627)ELV022803173
|
773 |
1 |
8 |
|g volume:89
|g year:2013
|g pages:15-17
|g extent:3
|
856 |
4 |
0 |
|u https://doi.org/10.1016/S0378-3782(13)70083-5
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_U
|
912 |
|
|
|a GBV_ELV
|
912 |
|
|
|a SYSFLAG_U
|
912 |
|
|
|a SSG-OLC-PHA
|
912 |
|
|
|a GBV_ILN_130
|
912 |
|
|
|a GBV_ILN_350
|
936 |
b |
k |
|a 44.45
|j Immunologie
|q VZ
|
951 |
|
|
|a AR
|
952 |
|
|
|d 89
|j 2013
|h 15-17
|g 3
|y 89.2013, S15-, (3 S.)
|
953 |
|
|
|2 045F
|a 610
|